Keratin expression in human tissues and neoplasms

Histopathology

Volumn 40, Issue 5, 2002, Pages 403-439

  Chu, Peiguo G ^a   Weiss, L M ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Diagnostic surgical pathology; Immunohistochemistry; Keratin

Indexed keywords

ANTIBODY; KERATIN;

BASAL CELL; BONE TUMOR; BREAST CARCINOMA; CORNEA; CYTOLOGY; EPIDERMIS; EPITHELIUM; FEMALE GENITAL TRACT CANCER; GASTROINTESTINAL CARCINOMA; HEAD AND NECK CARCINOMA; HUMAN; INTERMEDIATE FILAMENT; KERATINIZATION; MALE GENITAL TRACT CANCER; MALIGNANT MESOTHELIOMA; MALIGNANT TRANSFORMATION; MESENCHYME; MOLECULAR BIOLOGY; NEOPLASM; NEUROENDOCRINE DISEASE; ORGAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; REVIEW; SKIN APPENDAGE; SKIN CARCINOMA; SKIN DISEASE; SOFT TISSUE TUMOR; SQUAMOUS EPITHELIUM; STAINING; STRATIFICATION; URINARY TRACT CARCINOMA;

CHROMOSOME MAPPING; EPITHELIUM; GENE EXPRESSION; GENETIC DISEASES, INBORN; HUMANS; KERATINS; MUTATION; NEOPLASMS;

EID: 0036090767     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.01387.x     Document Type: Review

References (297)

1. Molecular and cellular biology of intermediate filaments
2. Organization and sequence of the human gene encoding cytokeratin 8
3. Intermediate filament proteins: A multi-gene family distinguishing major cell lineages
4. Low level expression of cytokeratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene
5. Two type II keratin genes are localized on human chromosome 12
6. Chromosomal assignments of human type I and type II cytokeratin genes to different chromosomes
7. Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12
8. The sequence of a type II keratin gene expressed in human skin: Conservation of structure among all intermediate filament genes
9. Inactivation of human keratin genes: The spectrum of mutations in the sequence of an acidic keratin pseudogene
10. Evolution of keratin genes: Different protein domains evolve by different pathways
11. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas
12. Intermediate-size filaments in a germ cell: Expression of cytokeratins in oocytes and eggs of the frog Xenopus
13. Epidermal keratin gene expressed in embryos of Xenopus laevis
14. Intrinsic and extrinsic regulation of the differentiation of skin, corneal and esophageal epithelial cells
15. Retinoids as important regulators of terminal differentiation: Examining keratin expression in individual epidermal cells at various stages of keratinization
16. Changes in keratin expression during the estrogen-mediated differentiation of rat vaginal epithelium
17. Identification and analysis of keratin polypeptides from isolated rat vaginal epithelium
18. Keratin modifications in epidermis, papillomas, and carcinomas during two-stage carcinogenesis in the SENCAR mouse
19. Effects of inhibitors of tumor promotion on 12-O-tetradecanoylphorbol-13-acetate-induced keratin modification in mouse epidermis
20. The catalog of human cytokeratins: Pattern of expression in normal epithelia, tumor and culture cells
21. Keratin classes: Molecular markers for different types of epithelial differentiation
22. Immunofluorescent staining of keratin fibers in cultured cells
23. Self-assembly of bovine epidermal keratin filaments in vitro
24. Protein complexes of intermediate-sized filaments: Melting of cytokeratin complexes in urea reveals different polypeptide separation characteristics
25. Structural and functional implications of amino acid sequences of keratin intermediate filament subunits
26. Differential expression of keratins 10, 17 and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma
27. Coiled coil formation and sequence regularities in the helical regions of alpha-keratin
28. Chemical cross-linking indicates a staggered and antiparallel protofilament of desmin intermediate filaments and characterizes one higher-level complex between protofilaments
29. The cytoskeleton and disease: Genetic disorders of intermediate filaments
30. Structure, function and dynamics of keratin intermediate filaments
31. The molecular biology of intermediate filaments
32. The cDNA sequence of a Type II cytoskeletal keratin reveals constant and variable structural domains among keratins
33. The cDNA sequence of a human epidermal keratin: Divergence of sequence but conservation of structure among intermediate filament proteins
34. Intermediate filament dynamics
35. The binding of vimentin to human erythrocyte membranes: A model system for the study of intermediate filament-membrane interactions
36. Site specificity in vimentin-membrane interactions: Intermediate filament subunits associate with the plasma membrane via their head domains
37. Intermediate filaments in disease
38. Epidermolysis bullosa simplex: Evidence in two families for keratin gene abnormalities
39. Human keratin diseases: The increasing spectrum of disease and subtlety of the phenotype-genotype correlation
40. Point mutation in human keratin 14 genes of epidermolysis bullosa simplex patients: Genetic and functional analysis
41. Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis
42. Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas
43. Cloning of multiple K16 genes and genotype-phenotype correlation in pachyonychia congenita type I and focal PPK
44. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2
45. Mutations in the 1A domain of keratin 9 in patients with epidermolytic palmoplantar keratoderma
46. Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK)
47. A mutation in the mucosal keratin K4 is associated with oral white sponge nevus
48. Keratin-13 point mutation underlies the hereditary mucosal epithelial disorder white sponge nevus
49. Meesmann's corneal dystrophy: Ultrastructural features
50. Mutation of human keratin 18 in association with cryptogenic cirrhosis
51. Keratin 8 mutations in patients with cryptogenic liver disease
52. Changes in keratin gene expression during terminal differentiation of the keratinocyte
53. Diversity of cytokeratins: Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues
54. Detection of a cytokeratin determinant common to diverse epithelial cells by a broadly cross-reacting monoclonal antibody
55. Transient synthesis of K6 and K16 keratins in regenerating rabbit corneal epithelium: Keratin markers for an alternative pathway of keratinocyte differentiation
56. Patterns of keratin expression define distinct pathways of epithelial development and differentiation
57. Cloning and characterization of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms
58. The mesothelial keratins: A new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia
59. Keratin 19: Predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins
60. Regulation of terminal differentiation of cultured human keratinocytes by vimentin A
61. A new small (40 kd) keratin filament protein made by some cultured human squamous cell carcinomas
62. Different keratin polypeptides in epidermis and other epithelia of human skin: A specific cytokeratin of molecular weight 46,000 in epithelia of the pilosebaceous tract and basal cell epitheliomas
63. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: An analysis of cytokeratin 20, p53, and CD44 antigens
64. An immunohistochemical study of cytokeratin 20 in human and mammalian oral epithelium
65. Keratin immunohistochemistry: Update on applications and pitfalls
66. Cytokeratins in smooth muscle cells and smooth muscle tumours
67. Cytokeratin-specific monoclonal antibodies are reactive with tumours of smooth muscle derivation. An immunocytochemical and biochemical study using antibodies to intermediate filament cytoskeletal proteins
68. Keratin 1 expression in endothelial and mesenchymal neoplasia
69. Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells
70. Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors
71. The use of antikeratin antibodies in the diagnosis of human neoplasms
72. Tumor diagnosis by intermediate filament typing: A novel tool for surgical pathology
73. Keratin cytoskeletons in epithelial cells of internal organs
74. Monoclonal antibodies to human intermediate filament proteins
75. Immunperoxidase localization of keratin in human neoplasms
76. Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors
77. Immunohistochemical localization of keratin-type proteins in epithelial neoplasms. Correlation with electron microscopic findings
78. Immunocytochemical characterization of lung tumors in fine-needle aspiration. The use of cytokeratin monoclonal antibodies for the differential diagnosis of squamous cell carcinoma and adenocarcinoma
79. Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression
80. A series of 14 new monoclonal antibodies to keratins: Characterization and value in diagnostic histopathology
81. Intraepidermal cytokeratin 7 expression is not restricted to Paget cells but is also seen in toker cells and Merkel cells
82. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas
83. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications and limitations
84. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma
85. Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues
86. Tissue distribution of keratin 7 as monitored by a monoclonal antibody
87. The expression of cytokeratins 7, 19, 20 in primary and metastatic carcinomas of the liver
88. OV-TL 12/30 (keratin 7 antibody) is a marker of glandular differentiation in lung cancer
89. The applicability of a keratin 7 monoclonal antibody in routinely Papanicolaou-stained cytologic specimens for the differential diagnosis of carcinomas
90. Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary
91. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases
92. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas
93. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas
94. Collecting duct carcinoma of kidney
95. Two distinct classes of keratin genes and their evolutionary significance
96. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies
97. Keratin 20: Immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinoma
98. Cytokeratin 20 immunoreactivity distinguishes merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites
99. Perianal Paget's disease. A histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma
100. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites
101. Expression of Keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas. An immunohistochemical study using monoclonal antibody AE 14
102. Cytokeratin staining in Merkel cell carcinoma: An immunohistochemical study of cytokeratins 5/6, 7, 17, and 20
103. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura
104. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma
105. Expression of cytokeratin 5/6 in epithelial neoplasms: An immunohistochemical study of 509 cases
106. Cytokeratin 14 expression in epithelial neoplasms: A survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial neoplasms
107. Cytokeratin 14 immunoreactivity distinguishes oncocytic tumor from its congeners: An immunohistochemical study of 31 cases
108. Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: An immunohistochemical study of sample and stratified epithelial-type cytokeratins
109. Immunohistochemical diagnosis of papillary thyroid carcinoma
110. Immunohistochemistry in the differential diagnosis of liver carcinomas
111. The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma
112. CK 7 expression in carcinomas of the Waldeyer's ring area
113. Immunohistochemcial study of basaloid squamous cell carcinoma, adenoid cystic and mucoepidermoid carcinoma in the upper aerodigestive tract
114. Application of immunohistochemistry to the diagnosis of salivary gland tumors
115. Keratin 14 immunoreactive cells in pleomorphic adenomas and adenoid cystic carcinomas of salivary glands
116. Salivary gland malignant myoepithelioma: A clinicopathologic and immunohistochemical study of ten cases
117. Characterization of the cellular component of polymorphous low-grade adenocarcinoma by immunohistochemistry and electron microscopy
118. Immunohistochemical detection of cytokeratin 18 and its neo-epitope in human salivary glands and pleomorphic adenomas
119. Endolymphatic sac tumor associated with a von Hippel-Lindau disease patient: An immunohistochemical study
120. Cytokeratin expression in trichoblastic fibroma (small nodular type trichoblastoma), trichoepithelioma and basal cell carcinoma
121. Expression of keratin 13, 14 and 19 in oral squamous cell carcinomas from Sudanese snuff dippers: Lack of association with human papillomavirus infection
122. Biochemical and immunohistochemical analyses of keratin expression in basal cell carcinoma
123. Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin
124. Cytokeratin 15 expression in trichoeptheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells
125. K15 expression implies lateral differentiation within stratified epithelial basal cells
126. An immunohistochemical study of the apocrine type of cutaneous mixed tumors with special reference to their follicular and sebaceous differentiation
127. Cytokeratin expression of apocrine and eccrine poromas with special reference to its expression in cuticular cells
128. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma
129. Immunohistochemical demonstration of keratins 8 and 14 in benign tumours of the skin appendage
130. Microcystic adnexal carcinoma. An immunohistochemical comparison with other cutaneous appendage tumors
131. Vulvar Paget's disease: A clinicopathologic and immunohistochemical study of 19 cases
132. Keratin proteins and carcinoembryonic antigen in lung carcinoma
133. Cytokeratins in normal lung and lung carcinomas
134. Cytokeratins and lung carcinomas
135. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas
136. Recent applications of immunoperoxidase histochemistry in human neuro-oncology: An update
137. Intranuclear inclusions of meningioma associated with abnormal cytoskeletal protein expression
138. Low-grade metaplastic carcinoma of the thymus
139. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile
140. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases
141. An unusual type of cytokeratin filament in cells of a human cloacogenic carcinoma derived from the anorectal transition zone
142. Cytokeratin polypeptide expression in a cloacogenic carcinoma and in the normal anal canal epithelium
143. Colon signet ring cell adenocarcinoma: Immunohistochemical characterization and comparison with gastric and typical colon adenocarcinomas
144. Keratin 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary
145. Complex cytokeratin polypeptide patterns observed in certain human carcinomas
146. Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer
147. Expression of intermediate filaments in normal and neoplastic exocrine pancreas
148. Cytokeratins and cell differentiation in the pancreas
149. Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder
150. Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer
151. Immunolocalization of cytokeratins in the normal and neoplastic human pituitary gland
152. Intermediate filaments as differentiation markers of exocrine pancreas. II. Expression of cytokeratins of complex and stratified epithelia in normal pancreas and in pancreas cancer
153. Adenosquamous carcinoma of the pancreas: A clinicopathologic series of 25 cases
154. Cytokeratin expression in hepatocellular carcinoma
155. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis
156. Hepatic stem-like cells in hepatoblastoma: Expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6
157. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach
158. The utility of cytokeratin subsets in distinguishing Barrett's related oesophageal adenocarcinoma from gastric adenocarcinoma
159. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms
160. Antibodies to cytokeratin 14 specially identify oncocytes (Hurthle cells) in thyroid lesions and tumors
161. Intermediate-filament proteins in parathyroid glands and parathyroid adenomas
162. Oncocytic adrenocortical neoplasms: A report of seven cases and review of the literature
163. Cytokeratin expression in adrenal phaechromocytomas and extra-adrenal paragangliomas
164. Expression of intermediate filaments in neuroendocrine tumors
165. Immunohistochemical distribution of simple-epithelial-type keratins and other intermediate filament proteins in the developing human pituitary gland
166. Cytokeratin subset markers in pituitary adenomas
167. Histological changes in the hypofunctional pituitary gland following conventional radiotherapy for adenoma
168. Intermediate filament expression in non-neoplastic pituitary cells
169. Immunohistochemical localization of intermediate filament and S-100 proteins in several non-endocrine cells of the human pituitary gland
170. Age-dependant pattern of intermediate filament protein expression in the human pineal gland
171. The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel cell) carcinoma of the skin, lymphoma, and oat cell carcinoma
172. Primary neuroendocrine (Merkel cell) carcinoma of the skin
173. Coexpression of cytokeratins 7 and 20 confirms urothelial carcinoma presenting as an intrarenal tumor
174. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases
175. Clear cell sarcoma of kidney in an adolescent and in young adults: A report of four cases with ultrastructural, immunohistochemical, and DNA flow cytometric analysis
176. Basal cell-specific and hyper proliferation-related keratins in human breast cancer
177. Cytokeratins in normal and malignant transitional epithelium
178. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression
179. Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases
180. Cytokeratin expression during neoplastic progression of human transitional cell carcinomas as detected by a monoclonal and a polyclonal antibody
181. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder
182. Cytokeratin 20 expression by non-invasive transitional cell carcinomas: Potential for distinguishing recurrent from non-recurrent disease
183. Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas
184. Immunohistochemistry of cytokeratin proteins in squamous and transitional cell lesions of the urinary tract
185. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer
186. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma
187. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma
188. Primary seminal vesicle carcinoma: An immunohistochemical analysis of four cases
189. Cytokeratin expression in seminoma of the human testis
190. Pattens of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: A study of 123 cases
191. Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma
192. The cytokeratin profile of medullary carcinoma of the breast
193. Small cell carcinoma of the breast: A clinicopathologic and immunohistochemical study of nine patients
194. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferation of the breast
195. Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas
196. Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells
197. Use of keratin 35βE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type benign and malignant intraductal proliferations
198. Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast
199. Cytokeratins of normal epithelia and some neoplasms of the female genital tract
200. Jejunal adenocarcinoma presenting as a primary ovarian carcinoma
201. Pulmonary metastases of colonic carcinoma. Distinction from pulmonary adenocarcinoma
202. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma
203. Ovarian endometrioid carcinomas simulating sex cord stromal tumors: A study using inhibin and cytokeratin 7
204. The dynamics of keratin expression in malignant transformation of cervical epithelium: A review
205. Can keratin 8 and 17 immunohistochemistry be of diagnostic value in cervical cytology? A feasibility study
206. Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical neoplasia
207. Epithelioid trophoblastic metastatic to the vagina: An immunohistochemical and ultrastructural study
208. Epithelioid trophoblastic tumor: A neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma
209. Brenner tumor of the ovary: A comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder
210. Female adnexal tumours of probable Wolffian origin: An immunohistochemical study comparing tumours, mesonephric remnants and paramesonephric derivatives
211. The immunohistochemical diagnosis of mesothelioma
212. Keratin subsets in spindle cell sarcomas
213. Extrarenal rhabdoid tumors of soft tissue: A clinicopathologic and immunohistochemical study of 18 cases
214. New immunocytochemical observations with diagnostic significance in cutaneous neuroendocrine carcinoma
215. Desmoplastic small cell tumors of the peritoneum coexpressing mesenchymal and epithelial markers
216. Chain-specific keratin profile of epithelioid soft-tissue sarcomas. An immunohistochemical study on synovial sarcoma and epithelioid sarcoma
217. Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas
218. Usefulness of cytokeratin subsets for distinguishing monophasic synovial sarcoma from malignant peripheral nerve sheath tumor
219. Epithelioid sarcoma: An immunohistochemistry analysis of 112 classical and variant cases and a discussion of the differential diagnosis
220. Cytokeratins in round cell sarcomas
221. Epithelioid sarcoma: An immunohistochemistry study
222. Intermediate filaments: Cell-type-specific markers in differentiation and pathology
223. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: Implications in tumor diagnosis
224. Angiosarcoma of soft tissue: A study of 80 cases
225. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases
226. Cytokeratin expression in epithelioid vascular neoplasms
227. Epithelioid angiosarcoma of the adrenal glands. A clinicopathologic study of nine cases with a discussion of the implications of finding 'epithelial-specific' markers
228. Keratin 1 expression in endothelia and mesenchymal tumors: An immunohistochemical analysis of normal and neoplastic tissues
229. Chordoma with a massive spindle-cell sarcomatous transformation: A light-and electron-microscopic and immunohistological study
230. Expression of cytokeratin 1, 5,14, 19 and transforming growth factors-beta1, beta2, beta3 in osteofibrous dysplasia and adamantinoma: A possible association of transforming growth factor-beta with basal cell phenotype promotion
231. Desmoplastic small round cell tumor II. An ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers
232. Desmoplastic small round cell tumors of the paratesticular region - A report of six cases
233. Intraabdominal desmoplastic small cell tumor: A light microscopic, immunocytochemical, ultrastructural and flow cytometric study
234. Renal chromophobe cell carcinoma and oncocytoma: A comparative morphologic, histological, and immunohistochemical study of 124 cases
235. Cytokeratin immunoreactivity in Ewing's sarcoma prevalence in 50 cases confirmed by molecular diagnostic studies
236. Immunohistochemical study of rhabdomyosarcoma. Unexpected staining with S100 protein and cytokeratin
237. An immunohistochemical study of differentiation in malignant fibrous histiocytoma
238. Cytokeratin expression in chondroblastomas
239. Epstein-Barr virus infection
240. Immunoreactive cytokeratins in plasmacytomas
241. IgD myeloma/immunoblastic lymphoma cells expressing cytokeratin
242. Frequent expression of hemopoietic and non-hemopoietic antigens by neoplastic plasma cells: An immunohistochemical study using formalin-fixed, paraffin-embedded tissue
243. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas
244. Cytokeratin in anaplastic large cell lymphoma
245. CD30 (Ki-1)-positive, anaplastic large cell lymphoma mimicking gastrointestinal carcinoma
246. Gastric large cell lymphoma expressing cytokeratin but no leukocyte common antigen
247. Cytokeratin positive large cell lymphomas of B-cell lineage
248. A case of keratin-positive acute myeloid leukemia: A possible role for cytokeratin 19 as a specific epithelial marker
249. Common acute lymphoblastic leukemia-lymphoma expressing cytokeratin: A case report
250. An immunohistochemical study of keratin expression in ameloblastoma from a Kenyan population
251. S-100, alpha-smooth muscle actin and cytokeratin 19 immunohistochemistry in odontogenic and soft tissue myxomas
252. Clear cell odontogenic carcinoma in the mandible: Histochemical and immunohistochemical observations with a review of the literature
253. Differentiation of odontogenic keratocysts from nonkeratinizing cysts by use of fine-needle aspiration biopsy and cytokeratin-10 staining
254. CK13 in craniopharyngioma versus related odontogenic neoplasms and human enamel organ
255. Immunohistochemical localization of keratin in craniopharyngiomas and squamous cell nests of the human pituitary
256. Cytokeratin immunoreactivity in gliomas
257. Intermediate filament expression in astrocytic neoplasms
258. Evaluation of epithelial and keratin markers in glioblastoma multiforme - An immunohistochemical study
259. Secretory meningioma, a rare meningioma subtype with characteristic glandular differentiation: An histological and immunohistochemical study of 9 cases
260. Epithelial differentiation in meningiomas. An immunohistochemical, histochemical, and ultrastructural study - With review of the literature
261. Choroid plexus neoplasms - Clinicopathologic and immunohistochemical studies
262. Ependymal and choroid plexus tumors - Cytokeratin and GFAP expression
263. Intermediate filament proteins in choroid plexus and ependyma and their tumors
264. Choroid plexus papillomas: An immunohistological study of 16 cases
265. Molecular characterization of the body site-specific human epidermal cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of gene expression
266. Isolation and chromosomal localization of a cornea-specific human keratin 12 gene and detection of four mutations in Measmann corneal epithelial dystrophy
267. Remarkable conservation of structure among intermediate filament genes
268. Structure of a gene for the human epidermal 67-kDa keratin
269. Cytokeratin and mucin expression in intestinal-type sinonasal adenocarcinomas
270. Immunohistochemical analysis of cytokeratin expression in various trichogenic tumors
271. Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin
272. Immunohistochemical analysis of keratin expression in clear cell syringoma. A comparative study with conventional syringoma
273. Cytokeratin 7 staining in mammary and extramammary Paget's disease
274. An immunohistochemical study of basal cell carcinoma and trichepithelioma
275. Cytokeratin 20: A marker for diagnosing Merkel cell carcinoma
276. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies
277. Keratin in human lung tumors
278. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets
279. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: A study with logistic regression analysis
280. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach
281. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: Differential diagnosis between colonic and ovarian carcinomas as primary sites
282. Solid-pseudeopapillary tumor of the pancreas: Immunohistochemical localization of neuroendocrine markers and CD10
283. Cytokeratins 7, 17 and 20 reactivity in pancreatic and ampulla of Vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold
284. Combined hepatocellular and cholangiocarcinoma
285. Cytokeratin polypeptide in gastrointestinal adenocarcinoma displaying squamous differentiation
286. Adenocarcinomas metastatic to the liver
287. Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver
288. Immunohistochemical expression of cytokeratins in intrahepatic cholangiocarcinoma and metastatic adenocarcinoma of the liver
289. Pleomorphic carcinoma of the breast: Clinicopathological analysis of 26 cases of an unusual high-grade phenotype of ductal carcinoma
290. Keratin immunoreativity in the benign and neoplastic human prostate
291. Immunohistochemical detection of cytokeratin and epithelial membrane antigen in leiomyosarcoma: A systematic study of 100 cases
292. Cytokeratin immunoreactivity in 41 cases of ES/PNET confirmed by molecular diagnostic studies
293. Aberrant cytokeratin subset immunoreactivity in sarcomas using a large panel of cytokeratin subset antibodies
294. Desmoplastic small round cell tumor: II. An ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers
295. Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study
296. Keratin expression in astrocytomas: An immunofluorescent and biochemical reassessment
297. The use of immunomorphology to differentiate choroid plexus tumors from metastatic carcinomas